High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease. [electronic resource]
Producer: 20190619Description: 1395-1401 p. digitalISSN:- 1478-3231
- 2-Naphthylamine
- Adult
- Anilides -- therapeutic use
- Antiviral Agents -- therapeutic use
- Carbamates -- therapeutic use
- Cohort Studies
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- complications
- Humans
- Lactams, Macrocyclic
- Liver Cirrhosis -- virology
- Macrocyclic Compounds -- therapeutic use
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Registries
- Renal Insufficiency, Chronic -- complications
- Ribavirin -- therapeutic use
- Ritonavir -- therapeutic use
- Saudi Arabia
- Sulfonamides -- therapeutic use
- Sustained Virologic Response
- Uracil -- analogs & derivatives
- Valine
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.